Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2Thromboembolism 2Neoplasms 2Vulvar Neoplasms 1Venous Thromboembolism 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Sarcoma 1Pulmonary Embolism 1Postoperative Complications 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

apixaban 4Dalteparin 4edoxaban 3Enoxaparin 3Rivaroxaban 2Fondaparinux 2Dabigatran 2Warfarin 1Intermittent Pneumatic Compression Devices 1Heparin, Low-Molecular-Weight 1Heparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Venous Thrombosis × Fondaparinux × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

University of Alabama at Birmingham

Phase 3 Terminated
7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡